1157 GMT - Danone could have an improvement in its infant-nutrition segment driven by the rise in birth rates in China, Barclays analysts say in a note. Especially given its material presence and significant market-share gains, the analysts add. After eight years of declines, China's National Bureau of Statistics recorded a birth rate increase of around 6% in 2024, they say. China accounts for roughly 40% of Danone's total infant-nutrition sales, the analysts say. Aptamil is the biggest brand across its entire portfolio, with sales of more than 3 billion euros, they say. China accounts for 50% of the global infant-formula market by value, and Danone currently holds a 13% market share, they say. However, it remains uncertain whether the increasing birth rate is a change in the trend or a mostly horoscope-related effect, as 2024 was the Year of the Dragon--a period which is traditionally associated with good fortune in Chinese culture, Barclays says. Shares are up 0.6% at 65.30 euros. (michael.susin@wsj.com)
(END) Dow Jones Newswires
January 20, 2025 06:57 ET (11:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。